Key Financial Data Of Reporting Company

Immuno-Biological Laboratories Co., Ltd. - Filing #7597262

Concept 2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
2019-04-01 to
2020-03-31
As at
2020-03-31
2019-04-01 to
2020-03-31
As at
2020-03-31
As at
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
As at
2019-03-31
As at
2018-03-31
As at
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
603,855,000 JPY
647,576,000 JPY
531,820,000 JPY
602,749,000 JPY
500,062,000 JPY
576,692,000 JPY
630,752,000 JPY
781,215,000 JPY
643,359,000 JPY
758,286,000 JPY
Ordinary profit (loss)
-69,963,000 JPY
-243,472,000 JPY
-196,675,000 JPY
-310,511,000 JPY
-503,432,000 JPY
-678,762,000 JPY
-159,794,000 JPY
-155,747,000 JPY
-48,258,000 JPY
-49,013,000 JPY
Profit (loss)
-123,641,000 JPY
-219,107,000 JPY
-547,128,000 JPY
-179,050,000 JPY
-63,920,000 JPY
Share capital
3,029,041,000 JPY
3,029,041,000 JPY
3,029,041,000 JPY
2,792,510,000 JPY
2,636,302,000 JPY
Total number of issued shares
9,314,590 xbrli:shares
9,314,590 xbrli:shares
9,314,590 xbrli:shares
8,724,590 xbrli:shares
8,333,090 xbrli:shares
Net assets
1,368,348,000 JPY
1,719,385,000 JPY
1,629,282,000 JPY
1,845,193,000 JPY
1,948,457,000 JPY
2,064,300,000 JPY
2,145,763,000 JPY
2,140,609,000 JPY
2,007,243,000 JPY
2,017,777,000 JPY
Total assets
1,705,338,000 JPY
1,997,942,000 JPY
1,838,038,000 JPY
1,962,901,000 JPY
2,372,989,000 JPY
2,439,750,000 JPY
2,988,314,000 JPY
2,911,068,000 JPY
3,242,166,000 JPY
3,295,015,000 JPY
Net assets per share
146.92
184.61
174.70
197.88
208.97
221.41
245.47
244.88
240.37
241.64
Dividend paid per share
Interim dividend paid per share
Basic earnings (loss) per share
-13.27
-27.78
-23.52
-34.23
-62.24
-76.00
-21.21
-19.82
-8.51
-7.01
Diluted earnings per share
Equity-to-asset ratio
0.802 xbrli:pure
0.861 xbrli:pure
0.885 xbrli:pure
0.939 xbrli:pure
0.820 xbrli:pure
0.845 xbrli:pure
0.717 xbrli:pure
0.734 xbrli:pure
0.618 xbrli:pure
0.611 xbrli:pure
Rate of return on equity
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Price-earnings ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Payout ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
-93,204,000 JPY
-194,145,000 JPY
-608,746,000 JPY
-243,935,000 JPY
73,847,000 JPY
Net cash provided by (used in) investing activities
-155,629,000 JPY
-17,233,000 JPY
10,818,000 JPY
-593,279,000 JPY
-6,278,000 JPY
Net cash provided by (used in) financing activities
143,998,000 JPY
-216,000,000 JPY
81,195,000 JPY
-126,320,000 JPY
-138,300,000 JPY
Cash and cash equivalents
449,184,000 JPY
552,022,000 JPY
974,456,000 JPY
1,491,808,000 JPY
2,450,875,000 JPY
Number of employees
63 xbrli:pure
62 xbrli:pure
63 xbrli:pure
62 xbrli:pure
65 xbrli:pure
58 xbrli:pure
65 xbrli:pure
56 xbrli:pure
61 xbrli:pure
52 xbrli:pure
48 xbrli:pure
57 xbrli:pure
Average number of temporary employees
7 xbrli:pure
7 xbrli:pure
7 xbrli:pure
7 xbrli:pure
9 xbrli:pure
7 xbrli:pure
11 xbrli:pure
9 xbrli:pure
9 xbrli:pure
7 xbrli:pure
9 xbrli:pure
11 xbrli:pure
Total shareholder return
0.40 xbrli:pure
0.68 xbrli:pure
0.66 xbrli:pure
0.88 xbrli:pure
1.80 xbrli:pure
Total return on share price index
0.64 xbrli:pure
0.82 xbrli:pure
0.64 xbrli:pure
0.96 xbrli:pure
1.41 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.